"Professor Jialai, when will the world's first cardiac surgery based on star stem cell technology be performed?" ..

When a reporter was honored to have the opportunity to ask questions, it couldn't wait to ask about heart surgery.

"On this point, we, Sumitomo Pharmaceutical and the Institute of Physics and Chemistry of Teito University, have conducted in-depth discussions with Professor Takuya Uchimura of Tokyo Central Hospital. So far, we have found suitable clinical trial patients. This time, Dr. Takuya Uchimura has The aortic arch and ascending aorta, which have tended to be necrotic, will be treated with a cardiac artery patch developed by the Institute of Physics and Chemistry of Tedo University. In the past, this was an extremely complicated and difficult operation, and it was often necessary for the patient to Ascending aorta and aortic arch replacement surgery is required, and Professor Uchimura is the best cardiac surgeon in Japan who is good at this type of surgery..."

"Because this operation uses a cardiac artery patch to treat the patient, the difficulty of the operation will be greatly reduced. Professor Uchimura now only needs to attach the cardiac artery patch to the patient's necrotic ascending aorta. And the aortic arch, the healthy arterial wall cells on the patch will automatically repair the damaged cells, so as to achieve the purpose of curing the patient. If you want to use a simple analogy, this technology is actually a bit similar to repairing a flat tire... …”

"Hahaha……"

As Shiori Tokunaga explained the difference of the operation in an easy-to-understand manner, there was a burst of happy laughter in the venue. The reporters present also showed great interest in this miraculous cardiac artery patch. You must know that anyone who knows a little about heart diseases will understand that myocardial tissue is a cell tissue that cannot be regenerated. Once damaged, it cannot be repaired. Now, the team led by Professor Hideki Kalai has broken this. Problems in the medical world. Using regenerative medicine to perform cell-level transplantation operations, the originally complicated operation has become simpler. And more importantly, this cell-level transplantation has more good curative effects and fewer side effects than traditional surgery.

When Shiori Tokunaga briefly explained the general plan of the star stem cell interventional heart surgery for the reporters present, the enthusiasm of the reporters on the scene also increased. Looking around from the podium, I saw that the audience was full of reporters who raised their hands to ask questions. Compared with the last press conference on retinal transplant surgery, this time was even more lively.

"The gentleman over there, may I...do you have any questions?"

"Hey, may I ask Professor Jialai, there were rumors that Sumitomo Pharma would cooperate with your team to establish a regenerative medicine company based on star stem cell technology. Excuse me... Is this rumor true?"

Hearing that the reporter actually asked Professor Calais questions directly, Shiori Tokunaga was naturally not good at answering on his behalf. So Hideki Calais turned on the microphone in front of him, and then replied to the reporter with a serious expression:

"About the establishment of a company, Sumitomo Pharmaceutical has already mentioned it to me a long time ago...but...because of the rigorous attitude of the researcher, I have been unable to make up my mind. Until the last retinal transplant operation After the announcement of success, I gradually realized that maybe our attitude was a little too conservative."

"Theoretically, star stem cells can differentiate into any tissue in the human body, which means that once this technology is promoted, any tissue and organ in the human body will have the ability to regenerate. I personally think that this This technology is very important for our country, which has entered an aging population. And this technology will also revolutionize many treatments in modern medicine. For example, we think that there is no cure and can only rely on drugs to maintain healthy diabetes patients , If one day we use the star stem cell technology to restore the patient's pancreatic islet function, will it be possible to fundamentally and completely cure diabetes?"

"It is to make this day a reality as soon as possible, so ... we need more funds and talents to invest in star stem cell research, and on the other hand, I think we also have an obligation to make some mature The technology will be applied clinically as soon as possible. For example, the cardiac artery patch applied in this operation is a very effective alternative to cardiac surgery. In order to make these similar excellent technologies no longer confined to the laboratory, I think… ...I can accept the use of commercial means to better promote this technology, so as to bring the gospel to more patients, this is what I, a researcher of regenerative medicine, really want to say..."

Hearing Professor Calais's sincere speech, the venue immediately burst into applause. Immediately afterwards, many reporters asked some questions about the research on star stem cells. Shiori Tokunaga, the representative of Sumitomo Pharmaceutical, also answered some related questions one by one.

"Professor Calais, it is said that you have become a strong contender for the Nobel Prize in Medicine this year. Do you have any expectations for this year's Nobel Prize?"

"Is this? I haven't thought about it at all. Maybe compared to the Nobel Prize, I can use star stem cell technology to bring health to more patients who are struggling with disease. It makes me feel more fulfilled. !"

...

After the press conference ~lightnovelpub.net~ Hideki Kalai and Takuya Uchimura, the cardiac surgery expert in charge of the clinical trial, had a chat for a while, and then couldn't wait to leave. At this moment, Shiori Tokunaga suddenly stopped Professor Calais, then pulled him aside and asked him carefully:

"Professor... Have you found a solution to the matter of Ueno Hiko Saburo? Dean Saito has been asking about your progress!"

"Oh...that...I'm still trying to find a solution, but the immune system is more complicated, so...in a while, I can't come up with a perfect solution. But... ...I believe that as long as the new company is established, I will be able to free up my hands, and I will definitely think of a safe treatment plan. By the way, how about the plan for the patient to take immunosuppressants, and whether the patient has symptoms Get relief!"

"This... I heard that there is still some effect, but this is only a way to treat the symptoms rather than the root cause. If things go on like this, Mr. Hiko Saburo's body will be overwhelmed..."

"Isn't this kind of situation very common in patients who have undergone transplant operations? In order to prolong their lives, there are not a few transplant patients who take immunosuppressive drugs for a long time. So... let's just observe it!"

(=)